Why bladder cancer gets missed, and why that needs to change – Bladder Cancer Awareness Month 2025
Bladder cancer is the 9th most common cancer in the world. In 2022, an estimated 614,000 new cases were diagnosed and over 1,9 million people were living with bladder cancer within five years of a past diagnosis . Every May the World Bladder Cancer Patient Coalition celebrates bladder cancer awareness month. Urinary tract cancers, including bladder cancer, are our main research focus here at Aqsens Health, which is why this year we wanted to take part in raising awareness for bladder cancer.
Aqsens Health starting pre-clinical trials for urinary tract cancer detection in China
Aqsens Health and its Chinese partner OG Pharmaceuticals have received funding for a joint prostate and bladder cancer pre-clinical and clinical research project in Jiangsu Province in China.
Aqsens Health, Tyks and Auria Biobank join forces for a research study to detect and classify bladder cancer with phage-biosensors
Aqsens Health, Turku University Hospital (Tyks) and Auria Biobank join forces for a bladder cancer research study. This local research collaboration aims to see whether Aqsens Health’s biosensors can be used in the detection and classification of bladder cancer, focusing especially on non-invasive monitoring of bladder cancer tumor development, relapse, and recurrence.
Bladder cancer FAQ – Bladder cancer awareness month 2023
What is bladder cancer and how is it currently diagnosed? How common is it? What are the usual symptoms? Every May the World Bladder Cancer Patient Coalition celebrates bladder cancer awareness month.